Transcutaneous pacing: Difference between revisions
| Line 5: | Line 5: | ||
**[[AV block]] | **[[AV block]] | ||
**Sinus node dysfunction | **Sinus node dysfunction | ||
*[[ | **[[A-fib]] with slow ventricular response | ||
**Malfunction of implanted pacemaker | **Malfunction of implanted pacemaker | ||
*Tachyarrhythmias causing hemodynamic impairment<ref name="AHA"></ref> | *Tachyarrhythmias causing hemodynamic impairment<ref name="AHA"></ref> | ||
Revision as of 12:45, 30 March 2019
Background
Indications
- Bradyarrhythmias causing hemodynamic impairment:[1]
- Tachyarrhythmias causing hemodynamic impairment[1]
Procedure
- Pad placement:
- Pad on apex of heart and on right upper chest
- Pad on lead V3 position and between left scapula and T-spine
- Set: HR 80, pacing threshold usually between 40-80 mA
- Look for clear QRS complex and T-wave following pacer spike
- Check pulse to confirm mechanical capture
- Final current set 5-10 mA above threshold level for patient
See Also
References
- ↑ 1.0 1.1 Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. May 27 2008;117(21):e350-408